Intravenous administration of anakinra in children with macrophage activation syndrome

• Main Authors: Omkar Phadke (Author), Kelly Rouster-Stevens (Author), Helen Giannopoulos (Author), Shanmuganathan Chandrakasan (Author), Sampath Prahalad (Author)
• Format: Book
• Published: BMC, 2021-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Subcutaneous anakinra is an interleukin-1 inhibitor used to treat juvenile idiopathic arthritis. Recent reports suggest anakinra can be a valuable addition to the treatment of COVID-19 associated cytokine storm syndrome and the related multisystem inflammatory syndrome (MIS-C) in...